Chemours Co. (CC) Stock Price Up 3.6%
Chemours Co. (NYSE:CC) rose 3.6% on Thursday . The stock traded as high as $12.99 and last traded at $12.83, with a volume of 1,058,465 shares traded. The stock had previously closed at $12.39.
CC has been the subject of several research reports. JPMorgan Chase & Co. reiterated a “hold” rating on shares of Chemours in a report on Wednesday, May 4th. Barclays PLC upped their price objective on Chemours from $14.00 to $15.00 and gave the stock an “overweight” rating in a research note on Monday, May 9th. Zacks Investment Research cut Chemours from a “buy” rating to a “hold” rating in a research note on Tuesday, May 10th. Argus restated a “hold” rating on shares of Chemours in a research note on Friday, May 13th. Finally, Vetr cut Chemours from a “hold” rating to a “sell” rating and set a $7.56 price objective for the company. in a research note on Wednesday, June 8th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $10.44.
The stock’s 50-day moving average is $9.77 and its 200 day moving average is $8.26. The firm’s market cap is $2.33 billion.
Chemours (NYSE:CC) last posted its earnings results on Tuesday, August 9th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.10. The business had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.42 billion. During the same period last year, the business earned ($0.10) EPS. Chemours’s revenue was down 8.3% compared to the same quarter last year. On average, equities research analysts predict that Chemours Co. will post $0.94 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 15th. Shareholders of record on Wednesday, August 17th will be paid a dividend of $0.03 per share. The ex-dividend date of this dividend is Monday, August 15th. This represents a $0.12 annualized dividend and a yield of 0.94%.
A number of hedge funds and institutional investors recently added to or reduced their stakes in the stock. Connor Clark & Lunn Investment Management Ltd. raised its position in Chemours by 213.2% in the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 193,735 shares of the company’s stock worth $1,038,000 after buying an additional 131,875 shares during the period. Schwab Charles Investment Management Inc. raised its position in Chemours by 25.1% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 387,325 shares of the company’s stock worth $2,077,000 after buying an additional 77,742 shares during the period. Finally, State of New Jersey Common Pension Fund D raised its position in Chemours by 1,700.0% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 900,000 shares of the company’s stock worth $4,824,000 after buying an additional 850,000 shares during the period.
The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Company’s Titanium Technologies segment manufactures titanium dioxide (TiO2), which is a pigment used to deliver whiteness, opacity, brightness and protection from sunlight in applications, such as architectural and industrial coatings, plastic packaging, polyvinyl chloride (PVC) window profiles, laminate papers, coated paper and coated paperboard used for packaging.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.